A new trading day began on Tuesday, with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stock price down -4.24% from the previous day of trading, before settling in for the closing price of $174.39. JAZZ’s price has ranged from $95.49 to $182.99 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -1.00% over the last five years. Meanwhile, its annual earnings per share averaged -62.09%. With a float of $57.98 million, this company’s outstanding shares have now reached $60.74 million.
Jazz Pharmaceuticals plc (JAZZ) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Jazz Pharmaceuticals plc is 4.59%, while institutional ownership is 100.45%. The most recent insider transaction that took place on Dec 09 ’25, was worth 379,366. In this transaction SVP, Technical Operations of this company sold 2,238 shares at a rate of $169.51, taking the stock ownership to the 19,508 shares. Before that another transaction happened on Dec 09 ’25, when Company’s Officer proposed sale 2,238 for $169.51, making the entire transaction worth $379,365.
Jazz Pharmaceuticals plc (JAZZ) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 6.6 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -62.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.11% during the next five years compared to -1.00% drop over the previous five years of trading.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Trading Performance Indicators
Here are Jazz Pharmaceuticals plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.44. Likewise, its price to free cash flow for the trailing twelve months is 7.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.07, a number that is poised to hit 6.39 in the next quarter and is forecasted to reach 22.46 in one year’s time.
Technical Analysis of Jazz Pharmaceuticals plc (JAZZ)
Analysing the last 5-days average volume posted by the [Jazz Pharmaceuticals plc, JAZZ], we can find that recorded value of 1.17 million was lower than the volume posted last year of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 69.51%.
During the past 100 days, Jazz Pharmaceuticals plc’s (JAZZ) raw stochastic average was set at 76.43%, which indicates a significant increase from 33.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.93 in the past 14 days, which was higher than the 3.90 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $160.05, while its 200-day Moving Average is $128.29. Now, the first resistance to watch is $173.19. This is followed by the second major resistance level at $179.40. The third major resistance level sits at $184.69. If the price goes on to break the first support level at $161.69, it is likely to go to the next support level at $156.40. Should the price break the second support level, the third support level stands at $150.19.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Key Stats
With a market capitalization of 10.15 billion, the company has a total of 60,765K Shares Outstanding. Currently, annual sales are 4,069 M while annual income is 560,120 K. The company’s previous quarter sales were 1,126 M while its latest quarter income was 251,410 K.
